WallStreetZenWallStreetZen

NASDAQ: RXRX
Recursion Pharmaceuticals Inc Stock Ownership - Who owns Recursion Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Recursion Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ben R. TaylorChief Financial Officer2025-09-157,057$4.83
$34.09kSell
Christopher GibsonChief Executive Officer2025-09-10100,000$4.71
$471.00kSell
Christopher GibsonChief Executive Officer2025-08-26100,000$4.84
$484.00kSell
Najat KhanChief RD Commercial Officer2025-08-1836,599$5.52
$202.17kSell
Christopher GibsonChief Executive Officer2025-08-1540,390$5.64
$227.80kSell
Ben R. TaylorChief Financial Officer2025-08-1511,908$5.64
$67.16kSell
Najat KhanChief RD Commercial Officer2025-08-153,789$5.64
$21.37kSell
Christopher GibsonChief Executive Officer2025-08-11100,000$5.28
$528.00kSell
Christopher GibsonChief Executive Officer2025-08-11500,300$5.28
$2.64MSell
Christopher GibsonChief Executive Officer2025-08-1117,875$5.28
$94.38kSell

1 of 6

RXRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RXRX insiders and whales buy or sell their stock.

RXRX Shareholders

What type of owners hold Recursion Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc8.31%36,071,178$174.58MInstitution
Ark Investment Management LLC7.60%32,988,631$159.66MInstitution
Lux Ventures IV LP6.98%30,308,614$146.69MInsider
Blackrock Inc6.53%28,371,063$137.32MInstitution
Baillie Gifford Co5.57%24,173,815$117.00MInstitution
Softbank Group Corp3.38%14,667,491$70.99MInstitution
Kinnevik Ab Publ3.09%13,434,171$65.02MInstitution
Mubadala Investment Co Pjsc2.99%12,985,927$62.85MInstitution
State Street Corp2.58%11,179,539$54.11MInstitution
Novo Holdings A2.23%9,665,128$46.78MInstitution

1 of 3

RXRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RXRX71.45%16.05%Net SellingNet Selling
ARQT76.78%23.22%Net SellingNet Selling
TVTX63.43%36.57%Net SellingNet Selling
AGIO76.13%23.87%Net SellingNet Selling
OCUL81.07%18.93%Net SellingNet Selling
View Top Biotech Stocks

Recursion Pharmaceuticals Stock Ownership FAQ

Who owns Recursion Pharmaceuticals?

Recursion Pharmaceuticals (NASDAQ: RXRX) is owned by 71.45% institutional shareholders, 16.05% Recursion Pharmaceuticals insiders, and 12.51% retail investors. Lux Ventures IV LP is the largest individual Recursion Pharmaceuticals shareholder, owning 30.31M shares representing 6.98% of the company. Lux Ventures IV LP's Recursion Pharmaceuticals shares are currently valued at $142.75M.

If you're new to stock investing, here's how to buy Recursion Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.